Socha M, Chmielewski J, Pietrus M, Wartega M
Int J Mol Sci. 2023; 24(16).
PMID: 37628922
PMC: 10454430.
DOI: 10.3390/ijms241612743.
Graves S, Esplin M, McGee P, Rouse D, Leveno K, Mercer B
Am J Obstet Gynecol. 2013; 210(4):328.e1-328.e5.
PMID: 24215859
PMC: 4130335.
DOI: 10.1016/j.ajog.2013.11.011.
Yalaz M, Levent E, Olukman M, Calkavur S, Akisu M, Kultursay N
Biomed Res Int. 2013; 2013:704763.
PMID: 23936837
PMC: 3722839.
DOI: 10.1155/2013/704763.
Steinberg C, Notterman D
Clin Pharmacokinet. 1994; 27(5):345-67.
PMID: 7851053
DOI: 10.2165/00003088-199427050-00003.
Lackner T, Valdes R
Eur J Clin Pharmacol. 1984; 26(4):531.
PMID: 6734711
DOI: 10.1007/BF00542152.
Studies of a digitalis-like autacoid in dog plasma.
BUCKALEW Jr V, Gruber K, Hennessy J
Trans Am Clin Climatol Assoc. 1983; 95:86-92.
PMID: 6147914
PMC: 2279603.
Digoxin toxicity in a premature infant: treatment with Fab fragments of digoxin-specific antibodies.
Presti S, Friedman D, Saslow J, DOYLE E, Butler V, Smith T
Pediatr Cardiol. 1985; 6(2):91-3.
PMID: 4059073
DOI: 10.1007/BF02282744.
Digitalis toxicity in infants and plasma digoxin levels.
Rutledge J
Pediatr Cardiol. 1985; 6(1):51-2.
PMID: 4011469
DOI: 10.1007/BF02265409.
Renal disease and digoxin immunoassays.
McElnay J, Hooymans P
Br Med J (Clin Res Ed). 1985; 291(6505):1319.
PMID: 3933648
PMC: 1417448.
DOI: 10.1136/bmj.291.6505.1319.
Digoxin levels in the serum of healthy neonates.
Malamitsi-Puchner A, Thanopoulos B, Christophoraki M, Constantellou E, Papathoma E, Simbruner G
Eur J Pediatr. 1986; 145(4):314-5.
PMID: 3770002
DOI: 10.1007/BF00439410.
Vasoconstrictor effects of endogenous digitalis-like factors extracted from urine of hypertensive patients.
Chiba S, Tsukada M, Katsuyama Y, Tada A, ZENDA H
Heart Vessels. 1987; 3(3):129-34.
PMID: 3440780
DOI: 10.1007/BF02058788.
The effect of renal and hepatic impairment and of spironolactone on digoxin immunoassays.
Morris R, Frewin D, Taylor W, Glistak M, Lehmann D
Eur J Clin Pharmacol. 1988; 34(3):233-9.
PMID: 3396618
DOI: 10.1007/BF00540949.
Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).
Besunder J, Reed M, Blumer J
Clin Pharmacokinet. 1988; 14(5):261-86.
PMID: 3293867
DOI: 10.2165/00003088-198814050-00001.
Digitalis toxicity in infancy and childhood.
Singh S
Indian J Pediatr. 1988; 55(1):27-34.
PMID: 3288559
DOI: 10.1007/BF02722556.
Circulating digitalis-like factors.
BUCKALEW Jr V
Pediatr Nephrol. 1988; 2(2):264-70.
PMID: 3153021
DOI: 10.1007/BF00862603.
Digoxin-like immunoreactive substance in patients with aneurysmal subarachnoid haemorrhage.
Wijdicks E, Vermeulen M, van Brummelen P, den Boer N, van Gijn J
Br Med J (Clin Res Ed). 1987; 294(6574):729-32.
PMID: 3105713
PMC: 1245792.
DOI: 10.1136/bmj.294.6574.729.
Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations.
Mooradian A
Clin Pharmacokinet. 1988; 15(3):165-79.
PMID: 3052985
DOI: 10.2165/00003088-198815030-00002.
Digoxin-like immunoreactive substance in serum of preterm and full-term neonates.
BERTRAND J, Langhendries J, Gras A, Battisti O
Eur J Pediatr. 1987; 146(2):145-6.
PMID: 3032639
DOI: 10.1007/BF02343220.
Digoxin-like substance in the serum of uremic patients before and after hemodialysis.
Durakovic Z, Ivanovic D, Durakovic A
Cardiovasc Drugs Ther. 1989; 2(6):757-60.
PMID: 2488089
DOI: 10.1007/BF00133205.
Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.
Gilman J
Clin Pharmacokinet. 1990; 19(1):1-10.
PMID: 2199125
DOI: 10.2165/00003088-199019010-00001.